Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens

Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens

Background The recommended reliance on 12 weeks posttreatment sustained virological response (SVR12) instead of SVR24 was validated for treatment evaluation. Aim Judging claimed concordance between SVR12 and SVR24. Patients and methods In a prospective study, 91 patients received sofosbuvir (SOF)+in...

Full description

Bibliographic Details
Main Authors: Maha M Elsabaawy, Khalid Gameel, Heba Eldemerdash, Talaat Zakareia, Mahmoud Eltahawy, Marry Albert, Marwa Fekry, Enas Ouda, Helmy Elshazly, Ashraf Eljaky
Format: Article
Language:English
Published: SpringerOpen 2019-01-01
Series:The Egyptian Journal of Internal Medicine
Subjects:
svr12
svr24
hcv
daas
Online Access:http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=4;spage=495;epage=501;aulast=Elsabaawy

Internet

http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=4;spage=495;epage=501;aulast=Elsabaawy

Similar Items